IneoQuesto Technologies, Inc.
USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04N (Pictorial Communication, e.g. Television).
The verdict
According to USPTO PatentsView, Ineoquesto ranks #19,900 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.
- #19,900
- of 49,997 US assignees by volume
- 29th percentile
- by Innovation Score (29.1/100)
- 19.6
- avg claims per patent
- -73%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R19900 · US Corporation #19,900 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 14 grants
- MID-PACK #19,900/49,997
- PHOTO-FINISH Imagine Scientific
- CPC-NARROW H04N · 5 areas
- INNOV-THIN 29.1/100
- CLAIMS-RICH 19.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -73% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Imagine Scientific, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ineoquesto’s 29.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ineoquesto
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- IneoQuesto · this assignee 29
IneoQuesto · this assignee
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ineoquesto's Innovation Score is 29.1/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ineoquesto?
Each dot is one of Ineoquesto’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ineoquesto’s own 19.6 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ineoquesto's grants concentrate
IneoQuesto Technologies, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 78.6% of grants classified under H04N (Pictorial Communication, e.g. Television). Peak complete grant year is 2016 (7 grants) versus a trough of 2 in 2015. By volume, Ineoquesto sits between Imagine Scientific, Inc. and Innotec Motion GmbH.
Who files at IneoQuesto's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Imagine Scientific
Imagine Scientific, Inc.
14 patents
- Immutrix Therapeu…
Immutrix Therapeutics, Inc.
14 patents
- Implant Direct Sy…
Implant Direct Sybron International LLC
14 patents
- Incelldx
IncellDx, Inc.
14 patents
- Ingenio
Ingenio, LLC
14 patents
- Inikoa Medical Ic
Inikoa Medical, Ic.
14 patents
- Innoblative Desig…
Innoblative Designs, Inc.
14 patents
- Innotec Motion
Innotec Motion GmbH
14 patents
- Ineoquesto ◀
IneoQuesto Technologies, Inc.
14 patents
What this shows IneoQuesto holds 14 patents at rank #19,922, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near IneoQuesto
By rank, the assignees closest to #19,922 in granted patent volume.
- Imagine Scientific, Inc. #19,918 · 14 patents
- Immutrix Therapeutics, Inc. #19,919 · 14 patents
- Implant Direct Sybron International LLC #19,920 · 14 patents
- IncellDx, Inc. #19,921 · 14 patents
- Ingenio, LLC #19,923 · 14 patents
- Inikoa Medical, Ic. #19,924 · 14 patents
- Innoblative Designs, Inc. #19,925 · 14 patents
- Innotec Motion GmbH #19,926 · 14 patents
Leaders in H04N (Pictorial Communication)
Other assignees with the most granted patents in IneoQuesto's primary technology class.
Ineoquesto's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 29th percentile higher than 29% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 14.3% |
| 2016 | 7 | 50.0% |
| 2017 | 2 | 14.3% |
| 2020 | 3 | 21.4% |
Which technologies does IneoQuesto Technologies, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
IneoQuesto Technologies, Inc.'s patent record in context - here's where to go next.
- IneoQuesto Technologies, Inc.'s lead technology class is H04N (Pictorial Communication, e.g. Television), 78.6% of its portfolio - see every assignee active in that class. Explore H04N
- Ranked #19,900 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare IneoQuesto Technologies, Inc. against Imagine Scientific, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.